Elyssa Ott
Impact in
-
- Psoriasis: Treatment and Pathogenesis
- Dermatology top 10%
- Dermatology and Skin Diseases
Papers in
-
- Psoriasis: Treatment and Pathogenesis 3
- Immunodeficiency and Autoimmune Disorders 3
- Genetics 6
- Inflammatory Bowel Disease 6
- Chronic Lymphocytic Leukemia Research 2
- Co-authors
- Arie Katz (1 shared paper)Chandrasekhar Udata (1 shared paper)Lisa Hickey (1 shared paper)Michael E. Burczynski (1 shared paper)Meng Xu (1 shared paper)O. Vesterqvist (1 shared paper)Subrata Ghosh (7 shared papers)Christopher Gasink (8 shared papers)
- Journals
- The American Journal of Gastroenterology (2 papers)Journal of Crohn s and Colitis (2 papers)Gastroenterology (2 papers)Drug Safety (1 paper)The Journal of Clinical Pharmacology (1 paper)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Elyssa Ott
13 papers receiving 478 citations
Peers
Comparison fields: 5 of 64
- Immunology 199
- Dermatology 71
- Genetics 118
- Surgery 164
- Rheumatology 54
Countries citing papers authored by Elyssa Ott
This map shows the geographic impact of Elyssa Ott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elyssa Ott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elyssa Ott more than expected).
Fields of papers citing papers by Elyssa Ott
This network shows the impact of papers produced by Elyssa Ott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elyssa Ott. The network helps show where Elyssa Ott may publish in the future.
Co-authors
The 25 scholars most cited alongside Elyssa Ott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 151 | |
| 2 | 2019 | 80 | |
| 3 | 2020 | 77 | |
| 4 | An update on the long-term safety experience of ustekinumab: results from the psoriasis clinical development program with up to four years of follow-up. | 2012 | 62 |
| 5 | 2019 | 42 | |
| 6 | 2005 | 33 | |
| 7 | 2024 | 17 | |
| 8 | 2018 | 12 | |
| 9 | 2022 | 11 | |
| 10 | 2021 | 3 | |
| 11 | 2023 | 1 | |
| 12 | 2021 | 1 | |
| 13 | 2021 | 1 | |
| 14 | 2021 | 0 |
About Elyssa Ott
Elyssa Ott is a scholar working on Immunology, Genetics, Public Health, Environmental and Occupational Health, Surgery and Hematology, having authored 14 papers that have together received 491 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (6 papers), Pregnancy and Medication Impact (3 papers), Psoriasis: Treatment and Pathogenesis (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Tuberculosis Research and Epidemiology (2 papers). The work is most often cited by research in Immunology (199 citations), Dermatology (71 citations), Genetics (118 citations), Surgery (164 citations) and Rheumatology (54 citations). Elyssa Ott has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Arie Katz, Chandrasekhar Udata, Lisa Hickey, Michael E. Burczynski, Meng Xu, O. Vesterqvist, Subrata Ghosh, Christopher Gasink, C Gasink and Soumya D. Chakravarty. Their work appears in journals such as The American Journal of Gastroenterology, Journal of Crohn s and Colitis, Gastroenterology, Drug Safety and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.